Acompanhe as Notícias da Recifes

Ensaio clínico sugere que, ao diminuir níveis da proteína tau, pacientes tenham um melhor prognóstico; diretora médica da farmacêutica explica. Destaque: 65%, 54%, 15%.

In Alzheimer's disease, amyloid plaques form in the brain, followed by threadlike structures made of the protein tau.

Brain-resident immune cells that have reached an old-age state called "senescence" secrete a protein that causes dysfunction in other brain cells, according to a study led by investigators at Weill Cornell Medicine.

In 1968, the American biochemist and geneticist Marshall Nirenberg and his colleagues won the Nobel Prize in physiology or medicine for their work deciphering how an organism's proteins are directly linked to its genetic code.

Descubra 5 combinações criativas com whey protein para variar seu consumo e potencializar resultados, com dicas de nutricionista.

Antisense oligonucleotides (ASOs) have been proposed as a therapeutic approach to shut down the production of faulty proteins in a wide variety of diseases, including cancer. In a study published in the Journal of Cell Biology (JCB), researchers at the Cancer Research UK Scotland

Scientists from St. Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangements. The finding identifies MBNL1 as a promising therapeutic targe

Researchers at Weill Cornell Medicine have uncovered how a key Parkinson's protein called LRRK2 shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state. Mutations that cause LRRK2 to bec

Pedido de patente de proteína aplicada ao diagnóstico de leishmaniose visceral é submetido ao INPI ricardo.valverde Seg, 10/08/2026 - 10:09

Scientists from Roswell Park Comprehensive Cancer Center report that the investigational anticancer agent FL118 functions as a dual molecular glue degrader that directly targets and degrades the proteins DDX5 and UbE2T, two emerging therapeutic targets linked to cancer survival m

Parkinson's disease affects more than 10 million people worldwide. The disease is characterized by the buildup of abnormal clumps of the protein alpha-synuclein inside brain cells, but scientists have long struggled to understand exactly how these toxic forms of the protein cause

Scientists have identified a molecular switch that may help explain why aging makes the brain more vulnerable to diseases such as ALS and Huntington’s. In worms, the protein EPS8 builds up with age and triggers signaling that encourages toxic proteins to clump together, damaging